-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ILCn2nQl80gOjH1GFsAt75O2+iik9vXPCZntXo+u39ncX5ABO0eM877S5+OO/3lY 5+kwj7ok6MWUVWvupjHf4g== 0001209191-03-018235.txt : 20030821 0001209191-03-018235.hdr.sgml : 20030821 20030821101533 ACCESSION NUMBER: 0001209191-03-018235 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030820 FILED AS OF DATE: 20030821 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GODDARD COLIN CENTRAL INDEX KEY: 0001225199 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15190 FILM NUMBER: 03859201 BUSINESS ADDRESS: STREET 1: OSI PHARMACEUTICALS INC STREET 2: 58 S. SERVICE RD. CITY: MELVILLE STATE: NY ZIP: 11747 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0201 42003-08-2000000729922OSI PHARMACEUTICALS INC OSIP0001225199GODDARD COLINC/O OSI PHARMACEUTICALS, INC.58 SOUTH SERVICE ROAD, SUITE 110MELVILLENY117471100Chief Executive OfficerCommon Stock2003-08-204M015003.25A11749DCommon Stock2003-08-204S0150035D10249DCommon Stock2003-08-204< transactionCode>M040004.25A14249DCommon Stock2003-08-204S0400035D10249DStock Option (Right to Buy)3.252003-08-204M015000D1999-09-232008-09-22Common Stock150034000DStock Option (Right to Buy)4.252003-08-204M040000D2000-06-232009-06-22Common Stock400016000DOne third of the stock option became exercisable one year after the date of the grant and the remainder vested ratably on a monthly basis over the succeeding 24 months.The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3.Includes only options with the same termination date.Robert L. Van Nostrand by Power of Attorney2003-08-21 -----END PRIVACY-ENHANCED MESSAGE-----